• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性成人卵巢颗粒细胞瘤的预后预测因子:系统评价和荟萃分析。

Prognostic predictors in recurrent adult granulosa cell tumors of the ovary: a systematic review and meta-analysis.

机构信息

Unità di Ginecopatologia e Patologia Mammaria, Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli 8, 00168, Roma, Italy.

Department of Advanced Biomedical Sciences, Pathology Section, School of Medicine, University of Naples "Federico II", Via Sergio Pansini, 5, 80131, Naples, Italy.

出版信息

Arch Gynecol Obstet. 2022 Aug;306(2):315-321. doi: 10.1007/s00404-021-06305-2. Epub 2021 Nov 19.

DOI:10.1007/s00404-021-06305-2
PMID:34799743
Abstract

BACKGROUND

Ovarian adult granulosa cell tumours are low-grade malignant sex cord-stromal neoplasm with a low recurrence rate. Prognostic factors for recurrence include tumor stage, tumor rupture in Stage I neoplasms and the presence of residual tumors after surgery. However, in recurrent tumors, prognostic factors for overall survival (OS) are lacking. In the present paper, we conducted a systematic meta-analysis with the aim to assess prognostic factors for OS in patients with recurrent GCT.

METHODS

Electronic databases were searched for all studies assessing prognostic factors in recurrent adult granulosa cell tumor of the ovary. Student T test, Fisher's exact test and Kaplan-Meier survival analysis with long-rank test were used to assess differences among groups; a p value < 0.05 was considered significant.

RESULTS

Eleven studies analyzing 102 recurrent tumors were included in the systematic review. Tumor stage and localization of recurrent tumors were significantly associated with OS on Kaplan-Meier analysis; Cox regression analysis showed a HR of 0.879 for the stage II, of 3.052 for the stage III, and of 2.734 for stage IV tumor was significantly associated with OS (p = 0.037); observed HRs for abdominal and thoracic locations were of 2.405 and of 4.024, respectively.

CONCLUSIONS

In conclusion, the present article emphasizes the prognostic significance of tumor stage > II and extrapelvic anatomic sites of recurrences in patients with recurrent granuolase cell tumors of the ovary.

摘要

背景

卵巢成人颗粒细胞瘤是低度恶性性索间质肿瘤,复发率低。复发的预后因素包括肿瘤分期、I 期肿瘤破裂和手术后残留肿瘤。然而,在复发性肿瘤中,缺乏总生存(OS)的预后因素。在本研究中,我们进行了一项系统的荟萃分析,旨在评估复发性 GCT 患者 OS 的预后因素。

方法

检索所有评估卵巢成人颗粒细胞瘤复发性肿瘤预后因素的研究。使用学生 T 检验、Fisher 确切检验和 Kaplan-Meier 生存分析结合 Long-rank 检验评估组间差异;p 值<0.05 认为有统计学意义。

结果

11 项研究分析了 102 例复发性肿瘤,纳入了系统综述。肿瘤分期和复发性肿瘤的定位与 Kaplan-Meier 分析的 OS 显著相关;Cox 回归分析显示 II 期肿瘤的 HR 为 0.879,III 期肿瘤的 HR 为 3.052,IV 期肿瘤的 HR 为 2.734,与 OS 显著相关(p=0.037);腹部和胸部的观察 HR 分别为 2.405 和 4.024。

结论

总之,本研究强调了肿瘤分期>II 期和复发性颗粒细胞瘤患者的盆腔外解剖部位对预后的重要性。

相似文献

1
Prognostic predictors in recurrent adult granulosa cell tumors of the ovary: a systematic review and meta-analysis.复发性成人卵巢颗粒细胞瘤的预后预测因子:系统评价和荟萃分析。
Arch Gynecol Obstet. 2022 Aug;306(2):315-321. doi: 10.1007/s00404-021-06305-2. Epub 2021 Nov 19.
2
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
3
Survival outcomes comparing minimally invasive versus open cytoreductive surgery in recurrent adult-type granulosa cell tumors.复发性成人型颗粒细胞瘤中微创与开放细胞减灭术的生存结果比较
Am J Obstet Gynecol. 2025 Jul;233(1):51.e1-51.e10. doi: 10.1016/j.ajog.2025.01.012. Epub 2025 Jan 15.
4
Treatment options for progression or recurrence of glioblastoma: a network meta-analysis.治疗胶质母细胞瘤进展或复发的选择:网络荟萃分析。
Cochrane Database Syst Rev. 2021 May 4;5(1):CD013579. doi: 10.1002/14651858.CD013579.pub2.
5
Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.超根治性(广泛)手术与标准手术治疗晚期上皮性卵巢癌的初步细胞减灭术。
Cochrane Database Syst Rev. 2022 Aug 30;8(8):CD007697. doi: 10.1002/14651858.CD007697.pub3.
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration.晚期、复发性或转移性子宫内膜癌的化疗:Cochrane协作网的系统评价
Ann Oncol. 2007 Mar;18(3):409-20. doi: 10.1093/annonc/mdl417. Epub 2006 Dec 5.
8
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
9
Ovarian Sertoli-Leydig cell tumours: A systematic review of relapsed cases.卵巢 Sertoli-Leydig 细胞瘤:复发病例的系统回顾。
Eur J Obstet Gynecol Reprod Biol. 2021 Aug;263:261-274. doi: 10.1016/j.ejogrb.2021.06.036. Epub 2021 Jun 28.
10
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.

引用本文的文献

1
Clinical features and survival rate of patients with ovarian granulosa cell tumor in Iran; a 10-year retrospective study.伊朗卵巢颗粒细胞瘤患者的临床特征和生存率:一项 10 年回顾性研究。
BMC Cancer. 2024 Oct 25;24(1):1318. doi: 10.1186/s12885-024-13069-w.
2
Risk Factors and Clinical Outcomes of Recurrence in Adult Ovarian Granulosa Cell Tumors.成人卵巢颗粒细胞瘤复发的风险因素和临床结局。
Cancer Rep (Hoboken). 2024 Oct;7(10):e70036. doi: 10.1002/cnr2.70036.
3
Sensitivity of frozen section analysis in patients with ovarian adult granulosa cell tumor, a multi-center study.

本文引用的文献

1
Retrospective analysis of clinicopathological characteristics of 19 ovarian juvenile granulosa cell tumor cases.回顾性分析 19 例卵巢幼年型颗粒细胞瘤的临床病理特征。
J Obstet Gynaecol Res. 2021 Jul;47(7):2492-2499. doi: 10.1111/jog.14805. Epub 2021 Apr 27.
2
Stage I juvenile granulosa cell tumors of the ovary: A multicentre analysis from the MITO-9 study.卵巢 I 期幼年型颗粒细胞瘤:来自 MITO-9 研究的多中心分析。
Eur J Surg Oncol. 2021 Jul;47(7):1705-1709. doi: 10.1016/j.ejso.2021.02.003. Epub 2021 Feb 9.
3
Adult granulosa cell tumors of the ovary: a clinicopathological study of 34 patients by the Hellenic Cooperative Oncology Group (HeCOG).
卵巢成人颗粒细胞瘤患者冰冻切片分析的敏感性:一项多中心研究。
Arch Gynecol Obstet. 2024 Oct;310(4):2167-2171. doi: 10.1007/s00404-024-07710-z. Epub 2024 Aug 30.
4
Complete reduction surgery of a huge recurrent adult granulosa cell tumor after neoadjuvant chemotherapy.新辅助化疗后巨大复发性成人颗粒细胞瘤的完全切除手术
Int Cancer Conf J. 2024 Feb 14;13(2):162-166. doi: 10.1007/s13691-024-00659-5. eCollection 2024 Apr.
5
Prognostic factors of adult granulosa cell tumors of the ovary: a Turkish retrospective multicenter study.卵巢成人颗粒细胞瘤的预后因素:土耳其回顾性多中心研究。
J Gynecol Oncol. 2024 May;35(3):e39. doi: 10.3802/jgo.2024.35.e39. Epub 2023 Dec 20.
6
The Prognostic Significance of Adjuvant Chemotherapy in Adult Ovarian Granulosa Cell Tumors: A Systematic Review and Meta-analysis.辅助化疗对成人卵巢颗粒细胞瘤的预后意义:系统评价和荟萃分析。
Cancer Control. 2023 Jan-Dec;30:10732748231215165. doi: 10.1177/10732748231215165.
7
ERβ in Granulosa Cell Tumors and Its Clinical Potential.卵巢颗粒细胞瘤中 ERβ 及其临床潜能
Endocrinology. 2023 Apr 17;164(6). doi: 10.1210/endocr/bqad063.
8
Clinical characteristics and oncological outcomes of recurrent adult granulosa cell tumor of ovary: A retrospective study of seventy patients.复发性成人卵巢颗粒细胞瘤的临床特征和肿瘤学结局:70 例回顾性研究。
Acta Obstet Gynecol Scand. 2023 Jun;102(6):782-790. doi: 10.1111/aogs.14558. Epub 2023 Apr 3.
9
Adult-Type Ovarian Granulosa Cell Tumour: Treatment Outcomes From a Single-Institution Experience.成人型卵巢颗粒细胞瘤:单机构经验的治疗结果
Cureus. 2022 Nov 3;14(11):e31045. doi: 10.7759/cureus.31045. eCollection 2022 Nov.
卵巢成人颗粒细胞瘤:希腊合作肿瘤学组(HeCOG)对34例患者的临床病理研究
Anticancer Res. 2008 Mar-Apr;28(2B):1421-7.